Creegan & Nassoura Financial Group’s Merck MRK Stock Holding History

Creegan & Nassoura Financial Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$3.33M	Sell	31,607 -625	-2%	-$58.7K	2.16%	12
2025 Q3	$2.71M	Sell	32,232 -4,220	-12%	-$348K	1.75%	19
2025 Q2	$2.89M	Buy	36,452 +915	+3%	+$72.7K	1.88%	16
2025 Q1	$3.19M	Hold	35,537	–	–	2.13%	13
2024 Q4	$3.54M	Hold	35,537	–	–	2.38%	11
2024 Q3	$4.04M	Hold	35,537	–	–	2.54%	9
2024 Q2	$4.4M	Sell	35,537 -50	-0.1%	-$6.44K	3.02%	7
2024 Q1	$4.7M	Sell	35,587 -220	-0.6%	-$27.1K	3.14%	7
2023 Q4	$3.9M	Hold	35,807	–	–	2.83%	7
2023 Q3	$3.69M	Sell	35,807 -275	-0.8%	-$29.6K	2.87%	8
2023 Q2	$4.16M	Hold	36,082	–	–	3.08%	5
2023 Q1	$3.84M	Hold	36,082	–	–	2.94%	6
2022 Q4	$4M	Sell	36,082 -56	-0.2%	-$5.72K	3.12%	6
2022 Q3	$3.11M	Buy	36,138 +58	+0.2%	+$5.18K	2.7%	8
2022 Q2	$3.29M	Sell	36,080 -173	-0.5%	-$15.3K	2.77%	8
2022 Q1	$2.98M	Sell	36,253 -72	-0.2%	-$5.68K	2.23%	15
2021 Q4	$2.78M	Buy	+36,325	New	+$2.89M	2.11%	15

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Creegan & Nassoura Financial Group's MRK Position: Q4 2025 in Review

Creegan & Nassoura Financial Group reduced its Merck (MRK) stake by 1.9% in Q4 2025, selling an estimated $58.7K and leaving 31,607 shares worth $3.33M. The position accounts for 2.16% of the portfolio, ranked #12.

Creegan & Nassoura Financial Group first reported a position in MRK in Q4 2021 and has held it in 17 quarters since. The position peaked at $4.7M in Q1 2024. 3,652 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

Creegan & Nassoura Financial Group held 31,607 shares of Merck worth $3.33M as of Q4 2025.
Creegan & Nassoura Financial Group sold 625 Merck shares in Q4 2025, an estimated $58.7K.
Merck made up 2.16% of Creegan & Nassoura Financial Group's portfolio in Q4 2025, its #12 holding.
Creegan & Nassoura Financial Group first reported a position in Merck in Q4 2021 and has held it in 17 quarters since.
Creegan & Nassoura Financial Group's Merck position peaked at $4.7M in Q1 2024.
3,652 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Creegan & Nassoura Financial Group's 13F filing for Q4 2025, filed 17 Feb 2026.